Literature DB >> 16556826

Science and law. Intellectual property and human embryonic stem cell research.

Jeanne F Loring1, Cathryn Campbell.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16556826     DOI： 10.1126/science.1120953

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

Review 2.  Moving research to patient applications through commercialization: understanding and evaluating the role of intellectual property.

Authors:  Robert M Patino
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-03       Impact factor: 1.232

3.  Embryonic stem cell patents and human dignity.

Authors:  David B Resnik
Journal:  Health Care Anal       Date:  2007-03-29

4.  Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells.

Authors:  Xuejun H Parsons; Yang D Teng; Dennis A Moore; Evan Y Snyder
Journal:  Recent Pat Regen Med       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.